Malignant peripheral nerve tumors of the oral cavity

DeVore, Duane T.; Waldron, Charles A.

doi:10.1016/0030-4220(61)90474-1

Cited by 25 publications

(1 citation statement)

References 32 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Thirty articles fulfilled the eligibility criteria, and 20 articles were identified in the hand search process. A total of 50 studies reporting 57 cases of MPNST in the oral and maxillofacial region were included in this systematic review (Ali et al, 2011; Arruda et al, 2016; Bagan et al, 2005; Bavitz & Chewning, 1990; Can et al, 1999; Chao et al, 2007; Chao, Levine, et al, 2007; Che et al, 2006; Chitale & Dickersin, 1983; Colmenero et al, 1991; David et al, 1978; Devore & Waldron, 1961; DiCerbo et al, 1992; do Amaral et al, 2016; Fernandes et al, 2006; Gangothri et al, 2011; Grätz et al, 1991; Grevers & Röcken, 1995; Guglielmotti et al, 1987; Habal, 1997; Haisa et al, 1996; Hamakawa et al, 1998; Hammond & Calderwood, 1969; Hoffmann et al, 1988; Hujala et al, 1993; Imamura et al, 2003; James et al, 2003; Janardhanan et al, 2011; Kameyama et al, 1987; Kenali et al, 1999; Lee et al, 2019; Majumdar et al, 2016; Martinez Devesa et al, 2006; Muraki et al, 1999; Olivier, 2017; Oztürk & Tutkun, 2012; Paeng et al, 2006; Patel et al, 2015; Probst et al, 2018; Ramalingam et al, 2012; Raveh et al, 1995; Roy et al, 2017; Sempere‐Ortega & Martinez‐San‐Millan, 2008; Seyhan et al, 2012; Sham et al, 2010; Shotton et al, 1988; Victoria et al, 1999; Yaga et al, 2015; Yamazaki et al, 2005; Zakhary et al, 2011). A flowchart of the selection process of the studies is illustrated in Figure .…”

Section: Resultsmentioning

confidence: 99%

Malignant peripheral nerve sheath tumour of the oral and maxillofacial region—A systematic review

et al. 2021

View full text Add to dashboard Cite

To integrate the available data published on malignant peripheral nerve sheath tumours (MPNST) of the oral and maxillofacial region. Searches in Embase, PubMed, Web of Science and Scopus were conducted for the identification of case reports/case series in English language. The risk of bias was assessed using the Joanna Briggs Institute tool. Outcomes were evaluated by Cox regression and Kaplan–Meier methods. A total of 306 articles were retrieved, 50 of which reporting 57 MPNST were included. The lesion showed a predilection for the mandible (n = 18/31.57%) of middle‐aged adults (~40.5 years) with a male/female ratio of 1.1:1. The individuals were mostly symptomatic with a mean evolution time of 9.6 months. Surgical removal plus adjuvant therapy (especially radiotherapy) was the main approach (51.86%). Recurrence was reported in 39.62% of cases. Nodal and distant metastases were identified in 28.26% and 26.66% of cases, respectively. The 2‐year cumulative survival rate was 55%. Independent predictors of poor survival were the presence of neurofibromatosis type 1 (p = 0.04) and distant metastases (p = 0.004). The diagnosis of MPNST is challenging due to the variety of its clinical and histopathological presentations. Local aggressiveness and the potential for metastases are common outcomes of this neoplasm.

show abstract

Section: Resultsmentioning

confidence: 99%

Malignant peripheral nerve sheath tumour of the oral and maxillofacial region—A systematic review

et al. 2021

View full text Add to dashboard Cite

show abstract

Nonmucosal Neoplasms of the Maxillofacial Region

Kaban¹,

Chuong²

1986

Head and Neck Management of the Cancer Patient

View full text Add to dashboard Cite

Das neurogene Sarkom im Kopf-Halsbereich mit Kontakt zur Sch�delbasis

Naujoks¹,

Wünsch

Ratzka

et al. 1981

Arch Otorhinolaryngol

View full text Add to dashboard Cite

The neurogenic sarcoma is a neoplasm found seldom. It descends from the sheaths of peripheric nerves. If this tumor develops from a solitary or multiple neurofibroma, it might also be called a neurofibrosarcoma. All other synonyms, especially that of the malignant schwannoma, should better be abandoned for histogenetic reasons. Today the classification of all tumors of the peripheral nervous system is based on a suggestion of the WHO from 1969. The tabular summary of the literature shows that only a little more than a hundred cases of neurogenic sarcoma of the head and neck were reported during the last 50 years. Differential diagnosis of this malignant tumor includes nearly all other malignant neoplasms of soft tissue, sometimes even anaplastic carcinoma. Histopathology, including electron microscopy, is described in general and also in detail with regard to three cases. Three forms of micro-morphological variants are dealt with, too. For diagnosis histological examination will be absolutely successful only in cases of neurofibromatosis or in cases where the nerve from which the tumor originates may be identified. Otherwise, conventional and computerized X-ray tomography may be helpful. Finally, some therapeutic and prognostic principles are discussed.

show abstract

Malignant peripheral nerve tumors of the oral cavity

Cited by 25 publications

References 32 publications

Malignant peripheral nerve sheath tumour of the oral and maxillofacial region—A systematic review

Malignant peripheral nerve sheath tumour of the oral and maxillofacial region—A systematic review

Nonmucosal Neoplasms of the Maxillofacial Region

Das neurogene Sarkom im Kopf-Halsbereich mit Kontakt zur Sch�delbasis

Contact Info

Product

Resources

About